financetom
Business
financetom
/
Business
/
Strathcona Resources Boosts Offer to Acquire MEG Energy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Strathcona Resources Boosts Offer to Acquire MEG Energy
Sep 8, 2025 4:21 AM

06:47 AM EDT, 09/08/2025 (MT Newswires) -- Strathcona Resources ( STHRF ) on Monday increased its offer to acquire all of MEG Energy's ( MEGEF ) common shares it does not already own for 0.80 of a Strathcona common share per MEG share. Its previous offer was for 0.62 of a Strathcona share and $4.10 in cash per MEG share.

The amended offer values MEG at C$30.86 per share and an 11% premium to the rival agreement entered into by MEG and Cenovus Energy ( CVE ). MEG on Aug. 28 struck a deal with Cenovus Energy ( CVE ) , under which Cenovus moved to acquire all of MEG's common shares in a deal that valued MEG at $27.79 per share as of Sept. 5. Strathcona said its amended offer reflects a 10% increase to Strathcona's original offer, which was valued at $28.02 per MEG Share as of September 5, 2025.

As previously disclosed, in the fourth quarter Strathcona intends to undertake a special distribution of $2.142 billion to all holders of Strathcona Shares as a dividend or, at the election of shareholders, a return of capital. If the amended offer is successful, the special distribution will equate to about $5.22 per Strathcona share. If the amended offer is unsuccessful, the special distribution will equate to about $10 per Strathcona share.

Strathcona said Waterous Energy Fund, its largest shareholder, has a long-term view of the business and has no plans to sell any of its Strathcona shares, "contrary to claims by the MEG board of directors."

The company also said the deal between MEG and Cenovus was "highly lopsided," which was reflected in the market reaction in the days following the announcement.

"This extraordinary outcome was the product of a MEG board of directors which has amongst the lowest share ownership in the Canadian oil and gas sector and a broken sale process which clearly generated little interest from other industry players and excluded Strathcona," Strathcona said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen to Invest $2 Billion in North Carolina Manufacturing Expansion
Biogen to Invest $2 Billion in North Carolina Manufacturing Expansion
Jul 21, 2025
07:45 AM EDT, 07/21/2025 (MT Newswires) -- Biogen (BIIB) said Monday it plans to invest an additional $2 billion in its manufacturing facilities at North Carolina's Research Triangle Park, building on nearly $10 billion invested in the area to date. The expansion will support the growth of its late-stage clinical pipeline across multiple modalities at its two RTP campuses, the...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
CoreWeave to Offer $1.5 Billion in Senior Notes due 2031
CoreWeave to Offer $1.5 Billion in Senior Notes due 2031
Jul 21, 2025
07:44 AM EDT, 07/21/2025 (MT Newswires) -- CoreWeave ( CRWV ) said Monday that it plans to offer $1.5 billion of senior notes due 2031 in a private offering. The company said it intends to use the proceeds for general corporate purposes, including repaying existing debt and covering fees and expenses related to the offering. The notes will be guaranteed...
BRIEF-Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
BRIEF-Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
Jul 21, 2025
July 21 (Reuters) - Iteos Therapeutics Inc ( ITOS ): * ITEOS THERAPEUTICS ENTERS INTO AGREEMENT TO BE ACQUIRED BY CONCENTRA BIOSCIENCES FOR $10.047 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT * ITEOS THERAPEUTICS ENTERS INTO AGREEMENT TO BE ACQUIRED BY CONCENTRA BIOSCIENCES FOR $10.047 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT * ITEOS THERAPEUTICS INC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved